Healthcare provider profile · identity verified

Michael E Clifford, MD

Family Practice · THE VILLAGES, FL · NPI 1821065657

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	736	224
Atorvastatin Calcium	Atorvastatin Calcium	723	230
Amlodipine Besylate	Amlodipine Besylate	506	155
Lisinopril	Lisinopril	456	144
Simvastatin	Simvastatin	422	131
Levothyroxine Sodium	Levothyroxine Sodium	378	108
Metoprolol Succinate	Metoprolol Succinate	362	111
Tamsulosin Hcl	Tamsulosin Hcl	345	121
Omeprazole	Omeprazole	302	99
Metformin Hcl	Metformin Hcl	280	88
Losartan Potassium	Losartan Potassium	268	84
Hydrochlorothiazide	Hydrochlorothiazide	242	72
Trazodone Hcl	Trazodone Hcl	217	72
Allopurinol	Allopurinol	198	65
Pantoprazole Sodium	Pantoprazole Sodium	195	68
Metoprolol Tartrate	Metoprolol Tartrate	167	56
Eliquis	Apixaban	157	51
Metformin Hcl Er	Metformin Hcl	134	42
Furosemide	Furosemide	130	50
Montelukast Sodium	Montelukast Sodium	122	37
Gabapentin	Gabapentin	120	47
Atenolol	Atenolol	112	32
Potassium Chloride	Potassium Chloride	99	32
Pioglitazone Hcl	Pioglitazone Hcl	97	33
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	30
Zolpidem Tartrate	Zolpidem Tartrate	92	30
Alprazolam	Alprazolam	85	36
Carvedilol	Carvedilol	81	24
Sertraline Hcl	Sertraline Hcl	80	25
Ozempic	Semaglutide	77	19
Sildenafil Citrate	Sildenafil Citrate	75	30
Escitalopram Oxalate	Escitalopram Oxalate	74	24
Meloxicam	Meloxicam	74	29
Clopidogrel	Clopidogrel Bisulfate	73	24
Finasteride	Finasteride	67	23
Glimepiride	Glimepiride	63	19
Fluticasone Propionate	Fluticasone Propionate	62	26
Ezetimibe	Ezetimibe	61	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	15
Tramadol Hcl	Tramadol Hcl	55	31
Hydralazine Hcl	Hydralazine Hcl	52	18
Duloxetine Hcl	Duloxetine Hcl	50	18
Fluoxetine Hcl	Fluoxetine Hcl	49	15
Pravastatin Sodium	Pravastatin Sodium	49	15
Ramipril	Ramipril	48	12
Doxazosin Mesylate	Doxazosin Mesylate	46	12
Prednisone	Prednisone	45	22
Valsartan	Valsartan	42	12
Ipratropium Bromide	Ipratropium Bromide	40	suppressed
Celecoxib	Celecoxib	38	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	35
Chlorthalidone	Chlorthalidone	37	12
Triamcinolone Acetonide	Triamcinolone Acetonide	37	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	11
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Lorazepam	Lorazepam	34	12
Propranolol Hcl	Propranolol Hcl	34	13
Temazepam	Temazepam	34	11
Albuterol Sulfate Hfa	Albuterol Sulfate	32	19
Amoxicillin	Amoxicillin	31	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	19
Fenofibrate	Fenofibrate	31	11
Lovastatin	Lovastatin	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	13
Famotidine	Famotidine	30	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	30	24
Spironolactone	Spironolactone	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Naproxen	Naproxen	29	16
Warfarin Sodium	Warfarin Sodium	29	12
Xarelto	Rivaroxaban	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Bumetanide	Bumetanide	28	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	11
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Azithromycin	Azithromycin	26	25
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	22
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Ketoconazole	Ketoconazole	25	14
Clonidine Hcl	Clonidine Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Methylprednisolone	Methylprednisolone	22	22
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Primidone	Primidone	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	16
Mirtazapine	Mirtazapine	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Irbesartan	Irbesartan	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Diazepam	Diazepam	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	15
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Acyclovir	Acyclovir	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Estradiol	Estradiol	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Glipizide	Glipizide	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Testosterone	Testosterone	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error